台湾重度至极重度感音神经性听力损失儿童双侧人工耳蜗植入的成本-效用分析
该研究采用四状态马尔可夫模型,从患者和台湾地区全民健康保险署(TNHIA)两个视角,评估双侧人工耳蜗植入(CI)相比双模式助听对重度至极重度感音神经性听力损失儿童的成本-效用。结果显示,同期双侧CI相比双模式助听,在TNHIA视角下的ICER为新台币232,662元/QALY,在患者视角下为新台币1,006,965元/QALY,按2022年台湾地区人均GDP的1至3倍阈值判断具有成本效果。
要点
- 同期双侧CI在两个视角下均优于序贯双侧CI(dominant)。
- 序贯双侧CI相比双模式助听的ICER在两个视角下均未超过台湾地区人均GDP的2倍。
- 单因素敏感性分析显示,双侧CI相对双模式助听的效用增益是最具影响的参数。
核心结论
- 在TNHIA和患者两个视角下,按2022年台湾地区人均GDP的1至3倍阈值判断,双侧CI均具有成本效果。
- 未来需要纳入其他维度成本与效果数据的研究,以帮助决策者更全面地评估双侧CI的成本效果。
研究设计与样本
- 采用四状态马尔可夫模型,状态包括「使用第一个内部装置」「使用第二个内部装置」「使用第三个内部装置」和「死亡」。
- 健康效用值来自对当地卫生专业人员的调查,并按量表调整以反映老龄化对听力的负面影响及生命早期获得治疗全部获益所需时间。
- 成本数据来自照护者调查、医院数据库、临床专家和TNHIA。
- 计算终身时间 horizon 的增量成本效果比(ICER),以每质量调整生命年(QALY)成本表示。
- 开展单因素敏感性分析和概率敏感性分析以考察不确定性和模型稳健性。
主要发现
- 基础案例分析显示,与双模式助听相比,双侧CI儿童获得更多QALY但花费更多成本。
- 从TNHIA视角,同期双侧CI相比双模式助听的ICER为新台币232,662元/QALY;从患者视角,ICER为新台币1,006,965元/QALY。
- 同期双侧CI在两个视角下均优于(dominated)序贯双侧CI。
- 序贯双侧CI相比双模式助听的ICER在两个视角下均未超过台湾地区人均GDP的2倍。
- 单因素敏感性分析显示,双侧CI相比双模式助听的效用增益在两个视角下均为最具影响的参数;概率敏感性分析证实了基础案例分析结果的稳健性。
关键数值与推荐
- 从TNHIA视角,同期双侧CI相比双模式助听的ICER为新台币232,662元/QALY。
- 从患者视角,同期双侧CI相比双模式助听的ICER为新台币1,006,965元/QALY。
- 同期双侧CI在两个视角下均优于序贯双侧CI。
- 序贯双侧CI相比双模式助听的ICER在两个视角下均未超过台湾地区人均GDP的2倍。
- 成本效果判断采用2022年台湾地区人均GDP的1至3倍作为阈值。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 未来需要纳入其他维度成本与效果数据的研究,以帮助决策者更全面地评估双侧CI的成本效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Cochlear implants are an option for children with sensorineural hearing loss who do not benefit from hearing aids. Although bilateral cochlear implantation (CI) has been shown to enhance hearing performance and quality of life, its cost-effectiveness remains unclear. This study aimed to evaluate the cost-effectiveness of bilateral CI compared with bimodal hearing for children with sensorineural hearing loss in Taiwan from both the perspectives of patients and Taiwan's National Health Insurance Administration (TNHIA). DESIGN: A four-state Markov model was utilized in the study, including "use the first internal device," "use the second internal device," "use the third internal device," and "death." Health utility values were obtained from a local survey of health professionals and then adjusted by a scale to reflect both the negative impact of aging on hearing and the time needed to develop the full benefit of treatment in the earliest years of life. The cost data were derived from a caregiver survey, hospital databases, clinical experts, and the TNHIA. The incremental cost-effectiveness ratio (ICER) was calculated over the lifetime horizon and presented as cost per quality-adjusted life year (QALY) to evaluate the cost-effectiveness of simultaneous bilateral CI, sequential bilateral CI, and bimodal hearing. In addition, one-way sensitivity analyses and probabilistic sensitivity analyses were conducted to investigate the impact of uncertainty and the robustness of the model. RESULTS: The base-case analysis showed that children with bilateral CI gained more QALYs while incurring more costs when compared with those with bimodal hearing. From the TNHIA perspective, compared with bimodal hearing, the ICER of simultaneous bilateral CI was New Taiwan Dollars 232,662 per QALY whereas from the patient perspective, the ICER was New Taiwan Dollars 1,006,965 per QALY. Moreover, simultaneous bilateral CI dominated sequential bilateral CI from both perspectives. Compared with bimodal hearing, the ICER of sequential bilateral CI did not exceed twice the gross domestic product per capita in Taiwan from either perspective. One-way sensitivity analysis demonstrated that the utility gain of bilateral CI compared with bimodal hearing was the most impactful parameter from both perspectives. Probabilistic sensitivity analysis confirmed the robustness of the base-case analysis results. CONCLUSIONS: Our findings reveal that bilateral CI was cost-effective when using the threshold of one to three times the 2022 gross domestic product per capita in Taiwan from both the TNHIA and patient perspectives. Future research incorporating cost and effectiveness data from other dimensions is needed to help decision-makers assess the cost-effectiveness of bilateral CI more comprehensively.
引用
- Lin TH, Lin PH, Fang TY, et al. Cost-Utility Analysis of Bilateral Cochlear Implants for Children With Severe-to-Profound Sensorineural Hearing Loss in Taiwan. Ear Hear. 2024. PMID: 39044334. doi:10.1097/AUD.0000000000001568
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。